ArticleDrug design, development and therapy2022

Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.

Zhaoqiang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.